| Expression pattern: |
UP |
| Associated gene: |
ROCK1 |
| Associated microRNA: |
miR-493-5p |
| Biological function: |
promotes cisplatin resistance and malignant progression (proliferation, cell cycle progression, migration/invasion) and inhibits apoptosis in DDP-resistant NSCLC cells |
| Molecular mechanism: |
ceRNA mechanism: circ_PIP5K1A sponges miR-493-5p to upregulate ROCK1 |
| Biological pathway or process: |
chemoresistance (promotes); proliferation (promotes); cell cycle (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; Transfection; MTT; Colony Formation Assay; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Luciferase Reporter Assay; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; Clinical Sample Validation |
| Clinical significance: |
circ_PIP5K1A might be applied as a biomarker to improve the DDP therapy for NSCLC patients. |
| Description: |
circ_PIP5K1A is upregulated in cisplatin (DDP)-resistant NSCLC tissues and resistant cell lines. It promotes chemoresistance and malignant behaviors by sponging miR-493-5p, thereby increasing ROCK1 expression, and it modulates DDP response in a cell line-derived xenograft model. |
| Confidence score: |
0.7857 |